Markets › LSE › HIK.L

Hikma Pharmaceuticals PLC

LSE:HIK.LHealthcareFTSE:ASXFTSE:MCX

£16.52−0.78%At closeAt close · Tue 20 Oct · ≈ AED 80.78 · Market cap $4.54B · Next earnings Thu 25 Feb

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	51.8%	51.0%	50.3%	48.9%	45.3%	43.0%	—	—
Operating margin	23.1%	24.8%	23.5%	12.8%	19.6%	17.3%	17.3%	+0.0 pts
Net margin	18.4%	16.5%	7.5%	6.6%	11.5%	12.3%	12.3%	+0.0 pts
EBITDA margin	27.0%	29.1%	19.3%	27.5%	25.2%	25.2%	—	—
Return on equity	20.2%	17.2%	8.8%	8.6%	15.5%	15.8%	15.7%	−0.1 pts
Return on assets	10.4%	9.6%	4.2%	4.1%	7.0%	7.2%	7.2%	+0.0 pts
Return on capital employed	17.4%	18.9%	17.4%	11.0%	19.4%	13.7%	—	—
Debt / equity	0.4×	0.3×	0.6×	0.5×	0.6×	0.6×	0.6×	−0.5%
Debt / assets	22.5%	19.4%	28.7%	25.4%	25.4%	28.3%	—	—
Interest coverage	9.6×	15.6×	7.7×	4.1×	8.2×	5.4×	—	—
Current ratio	1.9×	2.1×	1.9×	1.6×	1.1×	1.8×	1.8×	+0.0%
Quick ratio	1.1×	1.4×	1.1×	0.9×	0.6×	1.1×	—	—
Cash ratio	0.3×	0.4×	0.3×	0.2×	0.1×	0.2×	0.2×	+0.0%
Asset turnover	0.6×	0.6×	0.6×	0.6×	0.6×	0.6×	—	—
Inventory turnover	1.5×	1.8×	1.6×	1.6×	1.7×	1.7×	—	—
Receivables turnover	3.5×	3.3×	3.2×	3.6×	3.5×	3.1×	—	—
Dividend payout	25.3%	28.5%	66.5%	72.1%	48.7%	46.0%	—	—